All Stories

  1. Knowledge, Attitudes, and Practices of Iraqi Parents Regarding Antibiotic Use in Children and the Implications
  2. The COVID-19 pandemic in children and young people during 2022–24: what new did we learn?
  3. A population-based study of incident prescribing for hypercholesterolaemia and hypertension in Scotland: is the healthcare system recovering from the impact of COVID-19?
  4. Current access, availability and use of antibiotics in primary care among key low- and middle-income countries and the policy implications
  5. Impact of COVID-19 pandemic on the prescribing pattern of oral anticoagulants in the English primary care setting: a population-based segmented interrupted time series analysis of over 53 million individuals
  6. Use of sodium valproate and other antiseizure drug treatments in England and Wales: quantitative analysis of nationwide linked electronic health records
  7. Deriving and validating a risk prediction model for long COVID: a population-based, retrospective cohort study in Scotland
  8. ABSTRACTS of the 2024 ISPE Annual Meeting, Berlin, Germany, 24–28 August 2024
  9. Audit of antibiotic utilization patterns and practice for common eye infections at the ambulatory clinic of a teaching hospital in Ghana: Findings and implications
  10. Nephrotoxicity associated with aminoglycoside therapy in paediatrics: experiences from a leading referral hospital in Kenya
  11. Selecting the most informative positive and negative controls for self-controlled case series (SCCS): Rationale, approach, and lessons from studies investigating the safety of COVID-19 vaccines
  12. Impact of COVID-19 pandemic on the utilization and quality of antibiotic use in the primary care setting in England, March 2019–March 2023: a segmented interrupted time series analysis of over 53 million individuals
  13. Understanding Outcomes of COVID-19 Treatments including Antivirals and Antibodies across Scotland
  14. Impact of the COVID-19 pandemic on the utilisation and quality of antibiotic use in the Scottish primary care setting: a population-based segmented interrupted time-series analysis
  15. Response to: ‘letter to the editor: “A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials “’
  16. Patterns of initial and first‐intensifying antidiabetic drug utilization among patients with type 2 diabetes mellitus in Scotland, 2010–2020: A retrospective population‐based cohort study
  17. Managing infectious diarrhea among young children in community pharmacies in Saudi Arabia and the implications for AMR
  18. A qualitative study exploring the challenges and enablers of pharmacists with a recent background in community pharmacy transitioning into primary care
  19. Risk of winter hospitalisation and death from acute respiratory infections in Scotland: national retrospective cohort study
  20. Caveats in reporting of national vaccine uptake
  21. Analysis of the use of antibiotics by AWaRe categories during the COVID-19 pandemic in hospitals across Scotland: a national population-based study
  22. Antimicrobial stewardship capacity and antibiotic utilisation practices in the Cape Coast Teaching Hospital, Ghana: A point prevalence survey study
  23. Involving Patients and Clinicians in the Design of Wireframes for Cancer Medicines Electronic Patient Reported Outcome Measures in Clinical Care: Mixed Methods Study
  24. The Disruptive Impact of COVID-19 on the Utilization of Cancer Chemotherapy-Related Healthcare Assistance at the Principal Nationwide Referral Hospital in Kenya
  25. Selling antibiotics without prescriptions among community pharmacies and drug outlets: a simulated client study from Ghana
  26. Estimated indirect costs of haemodialysis versus peritoneal dialysis from a patients’ perspective at an Academic Hospital in Pretoria, South Africa
  27. Quality of ethnicity data within Scottish health records and implications of misclassification for ethnic inequalities in severe COVID-19: a national linked data study
  28. Data Resource Profile: The Hospital Electronic Prescribing and Medicines Administration (HEPMA) National Data Collection in Scotland
  29. Current rates of purchasing of antibiotics without a prescription across sub-saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistance
  30. Understanding and reporting odds ratios as rate-ratio estimates in case-control studies
  31. Ethnic inequalities in positive SARS-CoV-2 tests, infection prognosis, COVID-19 hospitalisations and deaths: analysis of 2 years of a record linked national cohort study in Scotland
  32. Assessment of the quality of antimicrobial prescribing among hospitalized patients in a teaching hospital in Ghana: findings and implications
  33. Trends in the Cost of Medicines, Consultation Fees and Clinic Visits in Malaysia’s Private Primary Healthcare System: Employer Health Insurance Coverage
  34. Airport based pharmacies; products, services and challenges essential for patients in a global travel landscape
  35. Involving Patients and Clinicians in the Design of Wireframes for Cancer Medicines Electronic Patient Reported Outcome Measures in Clinical Care: Mixed Methods Study (Preprint)
  36. Corrigendum to “Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications”
  37. Meta‐analysis of Factors Associated with Antidiabetic Drug Prescribing for Type 2 Diabetes Mellitus
  38. Perceptions of and Preparedness for the Application of Pharmacoeconomics in Practice, among Final Year Bachelor of Pharmacy Students in South Africa: A National Cross-Sectional Study
  39. Risk Awareness and Demographic Characteristics Associated With the Use of Sexual Enhancement Supplements Among University Staff: A Cross-Sectional Study in the United Arab Emirates
  40. Evaluation of duration of antibiotic therapy across hospitals in Scotland including the impact of COVID-19 pandemic: a segmented interrupted time series analysis
  41. Real-world effectiveness of systemic anticancer therapy for advanced melanoma in the west of Scotland from 2010 to 2018
  42. The impact of the COVID-19 pandemic on cardiovascular disease prevention and management
  43. Shedding light on community pharmacist–directed point-of-care screening and education for patients with kidney stones: Implications and future research
  44. Ongoing Efforts to Improve Antimicrobial Utilization in Hospitals among African Countries and Implications for the Future
  45. Assessing medication use patterns in patients hospitalised with COVID-19: a retrospective study
  46. Uptake of COVID-19 treatments in Scotland
  47. Effects of the COVID-19 pandemic on secondary care for cardiovascular disease in the UK: an electronic health record analysis across three countries
  48. Access to non-prescription medicines via vending machines: key considerations to help transfer the self-care concept to the next generation while managing safety risks
  49. An umbrella review and meta‐analysis of renin‐angiotensin system drugs use and COVID ‐19 outcomes
  50. Appropriateness of surgical antimicrobial prophylaxis in a teaching hospital in Ghana: findings and implications
  51. Tackling antimicrobial resistance across sub-Saharan Africa: current challenges and implications for the future
  52. A national, multicentre web-based point prevalence survey of antimicrobial use in community healthcare centres across South Africa and the implications
  53. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis
  54. Acceptability and Willingness of UAE Residents to Use OTC Vending Machines to Deliver Self-Testing Kits for COVID-19 and the Implications
  55. Impact of Parental Knowledge and Beliefs on HPV Vaccine Hesitancy in Kenya—Findings and Implications
  56. Characteristics and Management of Children With Suspected COVID-19 Admitted to Hospitals in India: Implications for Future Care
  57. Regional variation in longitudinal trajectories of primary care opioids prescribing across Health Boards in Scotland: a population-based study
  58. Assessing knowledge, attitude and practice of community pharmacists on the pain management and implications in UAE children
  59. Development and Validation of a Tool to Improve Community Pharmacists’ Surveillance Role in the Safe Dispensing of Herbal Supplements
  60. Evaluation of antibiotic prescribing for ambulatory patients seeking primary dental care services in a public hospital in Ghana: a clinical audit study
  61. What patient assessment skills do pharmacist independent prescribers require to prescribe immunomodulators in myeloma?
  62. The impact of the COVID-19 pandemic lockdown measures on the prescribing trends and utilization of opioids in the English primary care setting: segmented-liner regression analysis
  63. Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries
  64. An umbrella review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 outcomes: what do we know so far?
  65. Assessing the management of patients with type 2 diabetes in Bangladesh during pre- and post-COVID-19 era and the implications: A pilot study
  66. Top unresolved ethical challenges and dilemmas faced by community pharmacists in providing pharmaceutical care: Drawing the line between ethical challenges and the quality of the pharmaceutical care
  67. An umbrella review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 outcomes: what do we know so far?
  68. Obesity association with antidiabetic drugs’ prescription among patients with type 2 diabetes mellitus: a systematic review and meta-analysis
  69. The impact of the COVID-19 pandemic lockdown measures on the prescribing trends and utilisation of opioids in the English primary care setting: a segmented-linear regression analysis
  70. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: a systematic review and meta-analysis
  71. An umbrella review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 outcomes: what do we know so far?
  72. Biosimilars are essential for sustainable healthcare systems; however, key challenges remain as seen with long-acting insulin analogues
  73. Barriers and facilitators of adherence to antiretroviral treatment at a public health facility in Ghana: a mixed method study
  74. Management of Children Admitted to Hospitals across Bangladesh with Suspected or Confirmed COVID-19 and the Implications for the Future: A Nationwide Cross-Sectional Study
  75. Access to community pharmacy services for people with disabilities: Barriers, challenges, and opportunities
  76. Opportunities and challenges when using record linkage of routinely collected electronic health care data to evaluate outcomes of systemic anti-cancer treatment in clinical practice
  77. Patients' knowledge and practice on disposal of medicines kept in households in South Africa: Findings and implications
  78. Using Administrative Data from Public Health and Drug Programs
  79. Challenges and Innovations Brought about by the COVID-19 Pandemic Regarding Medical and Pharmacy Education Especially in Africa and Implications for the Future
  80. What matters to patients and clinicians when discussing the impact of cancer medicines on health-related quality of life? Consensus-based mixed methods approach in prostate cancer
  81. Key issues surrounding the management of non-communicable diseases including the management of diabetes post COVID-19 among developing countries with a specific focus on Bangladesh
  82. A national, multicentre web-based point prevalence survey of antimicrobial use and quality indices among hospitalised paediatric patients across South Africa
  83. Retrospective cohort study to evaluate medication use in patients hospitalised with COVID-19 in Scotland: protocol for a national observational study
  84. Use of Sedative‐Hypnotic Medications and Risk of Dementia: A Systematic Review and Meta‐Analysis
  85. Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications
  86. Frequency and determinants of domestic violence against Iranian women during the COVID-19 pandemic: a national cross-sectional survey
  87. Opioids and Gabapentinoids Utilisation and Their Related-Mortality Trends in the United Kingdom Primary Care Setting, 2010–2019: A Cross-National, Population-Based Comparison Study
  88. Pilot Study on the Current Management of Children with COVID-19 In Hospitals in Bangladesh; Findings and Implications
  89. Validity of Pneumonia Severity Assessment Scores in Africa and South Asia: A Systematic Review and Meta-Analysis
  90. Antimicrobial Stewardship Activities in Public Healthcare Facilities in South Africa: A Baseline for Future Direction
  91. Health systems, population and patient challenges for achieving universal health coverage for hypertension in Ghana
  92. Evidence-based public policy making for medicines across countries: findings and implications for the future
  93. Polypharmacy definition and prevalence in heart failure: a systematic review
  94. Current utilisation patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the future
  95. The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future
  96. A multicentre point prevalence study of antibiotics utilization in hospitalized patients in an urban secondary and a tertiary healthcare facilities in Nigeria: findings and implications
  97. Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries
  98. Activities in Namibia to Limit the Prevalence and Mortality from COVID-19 Including Community Pharmacy Activities and the Implications
  99. Assessment of adherence to pneumonia guidelines and its determinants in an ambulatory care clinic in Ghana: findings and implications for the future
  100. Influence of pharmaceutical services organization on the availability of essential medicines in a public health system
  101. A point prevalence survey of antimicrobial utilisation patterns and quality indices amongst hospitals in South Africa; findings and implications
  102. Development of a web-based application to improve data collection of antimicrobial utilization in the public health care system in South Africa
  103. Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications
  104. Key Issues Surrounding Appropriate Antibiotic Use for Prevention of Surgical Site Infections in Low- and Middle-Income Countries: A Narrative Review and the Implications
  105. Utilisation, Availability and Price Changes of Medicines and Protection Equipment for COVID-19 Among Selected Regions in India: Findings and Implications
  106. Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications
  107. Changes in availability, utilization, and prices of medicines and protection equipment for COVID-19 in an Urban population of Northern Nigeria
  108. Prevalence rate of spontaneously reported adverse events and determinants of serious adverse events amongst three outpatient care settings in ghana: findings and implications
  109. COVID-19, health care and self-medication issues in resource-limited settings: Findings and implications based on experiences in Ghana
  110. Health-Care professionals' knowledge and practice regarding disposal of medicines in primary health-care facilities in South Africa: Impact and implications
  111. The prevalence of medication errors among nursing students: A systematic and meta-analysis study
  112. Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future
  113. A systematic review and meta‐analysis of the use of renin‐angiotensin system drugs and COVID‐19 clinical outcomes: What is the evidence so far?
  114. Supporting antimicrobial stewardship in Ghana: evaluation of the impact of training on knowledge and attitudes of healthcare professionals in two hospitals
  115. A multicentre point prevalence survey of hospital antibiotic prescribing and quality indices in the Kurdistan Regional Government of Northern Iraq: The need for urgent action
  116. Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future
  117. Supporting global antimicrobial stewardship: antibiotic prophylaxis for the prevention of surgical site infection in low- and middle-income countries (LMICs): a scoping review and meta-analysis
  118. A systematic review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 clinical outcomes: What is the evidence so far?
  119. Compliance with South Africa’s Antimicrobial Resistance National Strategy Framework: are we there yet?
  120. Availability and price changes of potential medicines and equipment for the prevention and treatment of COVID-19 among pharmacy and drug stores in Bangladesh; findings and implications
  121. Lessons from the failure of implementing the ‘Better Care Better Value’ prescribing indicator for renin–angiotensin system drugs in England: a qualitative study of general practitioners’ perceptions using behavioural change framework
  122. Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future
  123. Evaluation of the prescribing decision support system Synonyms in a primary care setting: a mixed‐method study
  124. Real‐world evaluation of the impact of statin intensity on adherence and persistence to therapy: A Scottish population‐based study
  125. Use of record linkage to evaluate treatment outcomes and trial eligibility in a real‐world metastatic prostate cancer population in Scotland
  126. Translation and Validation of the Farsi Version of the Pain Management Self-Efficacy Questionnaire
  127. Review of Ongoing Activities and Challenges to Improve the Care of Patients With Type 2 Diabetes Across Africa and the Implications for the Future
  128. Antimicrobial point prevalence surveys in two Ghanaian hospitals: opportunities for antimicrobial stewardship
  129. Evaluation of the clinical practice of aminoglycoside use in paediatric patients in Kenya: findings and implications for lower-middle income countries
  130. Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries
  131. A Systematic Review and Meta-Analysis of the Use of Renin-Angiotensin System Blockers and COVID-19 Outcomes: What is the Evidence so Far and the Implications?
  132. Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future
  133. Proactive risk assessment of vincristine use process in a teaching and referral hospital in Kenya and the implications
  134. Pricing of oral generic cancer medicines in 25 European countries; fi ndings and implications
  135. Prescribing trends of inhaler treatments for asthma and chronic obstructive pulmonary disease within a resource-constrained environment in the Scottish national health service: findings and implications
  136. Clinical and economic implications of therapeutic switching of angiotensin receptor blockers to angiotensin-converting enzyme inhibitors
  137. Prevalence of metabolic syndrome among Iranian women with polycystic ovary syndrome: A systematic review and meta-analysis
  138. Adverse effects of chemotherapy and their management in Pediatric patients with Non-Hodgkin’s Lymphoma in Kenya: A descriptive, situation analysis study
  139. Ongoing initiatives within the Scottish National Health Service to affect the prescribing of selective serotonin reuptake inhibitors and their influence
  140. Feasibility of using point prevalence surveys to assess antimicrobial utilisation in public hospitals in South Africa: a pilot study and implications
  141. A Systematic Review and Meta-Analysis of Health Literacy in the Iranian Population: Findings and Implications
  142. Prevalence of depression among Iranian patients with rheumatoid arthritis: a systematic review and meta-analysis
  143. Health-related quality of life in Iranian patients with type 2 diabetes: An updated meta-analysis
  144. The use of probiotics as a supplementary therapy in the treatment of patients with asthma: a pilot study and implications
  145. Antibiotic prescribing patterns at a leading referral hospital in Kenya: A point prevalence survey
  146. Clinical and Financial Implications of Medicine Consumption Patterns at a Leading Referral Hospital in Kenya to Guide Future Planning of Care
  147. Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets
  148. Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination with Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
  149. Antibiotic consumption and antimicrobial resistance in Poland; findings and implications
  150. Prevalence of poststroke depression in Iranian patients: a systematic review and meta-analysis
  151. Comparison of Zidovudine and Tenofovir Based Regimens With Regard to Health-Related Quality of Life and Prevalence of Symptoms in HIV Patients in a Kenyan Referral Hospital
  152. Trends in the prescribing of antipsychotic medicines in Pakistan: implications for the future
  153. Adequacy of Dialysis in Iranian Patients Undergoing Hemodialysis: A Systematic Review and Meta-Analysis
  154. Validity of World Health Organisation prescribing indicators in Namibia’s primary healthcare: findings and implications
  155. Ongoing activities to optimize the quality and efficiency of lipid-lowering agents in the Scottish national health service: influence and implications
  156. Abstract
  157. Prevalence of depression among Iranian patients under hemodialysis: a systematic review and meta-analysis
  158. Evaluation of antihypertensive adherence and its determinants at primary healthcare facilities in rural South Africa
  159. Pilot study assessing the direct medical cost of treating patients with cancer in Kenya; findings and implications for the future
  160. Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications
  161. Point prevalence survey of antibiotic use and resistance at a referral hospital in Kenya: findings and implications
  162. Statin use in Brazil: findings and implications
  163. Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications
  164. Ongoing initiatives in Azerbaijan to improve the use of antibiotics; findings and implications
  165. Assessing Adherence to Antihypertensive Therapy in Primary Health Care in Namibia: Findings and Implications
  166. Prescription patterns and adequacy of blood pressure control among adult hypertensive patients in Kenya; findings and implications
  167. Exploring factors associated with patients’ adherence to antihypertensive drugs among people with primary hypertension in the United Kingdom
  168. Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia’s national referral hospital: a pilot study and the implications
  169. Initiatives to increase the prescribing of low cost generics; the case of Scotland in the international context
  170. The impact of the ‘Better Care Better Value’ prescribing policy on the utilisation of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for treating hypertension in the UK primary care setting: longitudinal quasi-experimental d...